Integra LifeSciences Holdings
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$1.54B N/A	$1.55B 0.98%	$1.54B -1.03%	Avg: $1.77B Low: $1.69B High: $1.81B avg. 14.94%	Avg: $1.85B Low: $1.81B High: $1.87B avg. 4.62%	Avg: $1.94B Low: $1.90B High: $1.96B avg. 4.96%
Net Income % change YoY	$169.07M N/A	$180.55M 6.78%	$67.74M -62.48%	Avg: $156.97M Low: $126.12M High: $167.10M avg. 131.72%	Avg: $208.5M Low: $161.38M High: $168.82M avg. 32.82%	Avg: $408.91M Low: $396.83M High: $415.13M avg. 96.12%
EBITDA % change YoY	$240.18M N/A	$276.72M 15.21%	$274.01M -0.98%	Avg: $284.48M Low: $271.47M High: $290.98M avg. 3.82%	Avg: $297.62M Low: $290.86M High: $301.11M avg. 4.62%	Avg: $312.41M Low: $305.31M High: $316.06M avg. 4.96%
EPS % change YoY	$2 N/A	$2.18 9.00%	$0.87 -60.09%	Avg: $1.85 Low: $1.57 High: $2.08 avg. 112.64%	Avg: $2.07 Low: $2.01 High: $2.1 avg. 11.89%	Avg: $5.09 Low: $4.94 High: $5.17 avg. 145.89%
Operating Expenses % change YoY	$747.41M N/A	$731.39M -2.14%	$836.39M 14.35%	Avg: $741.43M Low: $707.53M High: $758.37M avg. -11.35%	Avg: $775.68M Low: $758.06M High: $784.77M avg. 4.62%	Avg: $814.21M Low: $795.71M High: $823.75M avg. 4.96%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 86.89% in 2025-2027.

We have gathered data from 8 analysts. Their low estimate is 126.12M, average is 156.97M and high is 167.10M.

Wall Street analysts forecast annual average revenue growth of 8.17% in 2025-2027.

We have gathered data from 10 analysts. Their low revenue estimate is $1.69B, average is $1.77B and high is $1.81B.

Wall Street analysts forecast annual average earnings growth of 90.14% in 2025-2027.

We have gathered data from 8 analysts. Their low earnings per share estimate is $1.57, average is $1.85 and high is $2.08.

In the last twelve months analysts have been covering Integra LifeSciences Holdings stock. The most successful analyst is David Turkaly.